Drug Type Antibody drug conjugate (ADC) |
Synonyms Dox-anti-CD99, anti-CD99-doxorubicin ADC(Nanovalent) |
Target |
Action inhibitors |
Mechanism CD99 inhibitors(CD99 molecule (Xg blood group) inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H29NO11 |
InChIKeyAOJJSUZBOXZQNB-TZSSRYMLSA-N |
CAS Registry23214-92-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | United States | - |